Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer

Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer

Abstract Liquid biopsy has become a useful alternative in metastatic colorectal cancer (mCRC) patients when tissue biopsy of metastatic sites is not feasible. In this study we aimed to investigate the clinical utility of circulating exosomes DNA in the management of mCRC patients. Exosomes level and...

Full description

Bibliographic Details
Main Authors:	Donatella Lucchetti, Ina Valeria Zurlo, Filomena Colella, Claudio Ricciardi-Tenore, Mariantonietta Di Salvatore, Giampaolo Tortora, Ruggero De Maria, Felice Giuliante, Alessandra Cassano, Michele Basso, Antonio Crucitti, Ilaria Laurenzana, Giulia Artemi, Alessandro Sgambato
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-11-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-01668-7

Similar Items

Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity
by: Donatella Lucchetti, et al.
Published: (2020-01-01)

Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer
by: Donatella Lucchetti, et al.
Published: (2023-06-01)

Measuring Extracellular Vesicles by Conventional Flow Cytometry: Dream or Reality?
by: Donatella Lucchetti, et al.
Published: (2020-08-01)

CD147 Promotes Cell Small Extracellular Vesicles Release during Colon Cancer Stem Cells Differentiation and Triggers Cellular Changes in Recipient Cells
by: Donatella Lucchetti, et al.
Published: (2020-01-01)

Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection
by: Francesco Ardito, et al.
Published: (2021-04-01)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
by: Enrico Gurreri, et al.
Published: (2023-05-01)

Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren’s Classification in Pan–Cancer Analysis Era?
by: Ina Valeria Zurlo, et al.
Published: (2020-07-01)

KRAS-dependent sorting of miRNA to exosomes
by: Diana J Cha, et al.
Published: (2015-07-01)

Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives
by: Sergio Pannunzio, et al.
Published: (2024-01-01)

Mutant KRAS Exosomes Influence the Metabolic State of the Colon Microenvironment
by: Ranjan Preet, PhD, et al.
Published: (2018-01-01)

The Impact of <i>KRAS</i> Mutational Status on Long-Term Survival following Liver Resection for Hilar Cholangiocarcinoma
by: Francesco Ardito, et al.
Published: (2022-09-01)

The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
by: Miriam Grazia Ferrara, et al.
Published: (2021-12-01)

Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass
by: Tiziana Servidei, et al.
Published: (2023-04-01)

Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells
by: Qin Zhang, et al.
Published: (2018-01-01)

Does KRAS Play a Role in the Regulation of Colon Cancer Cells-Derived Exosomes?
by: Shu-Kee Eng, et al.
Published: (2021-01-01)

Cell-of-Origin and Genetic, Epigenetic, and Microenvironmental Factors Contribute to the Intra-Tumoral Heterogeneity of Pediatric Intracranial Ependymoma
by: Tiziana Servidei, et al.
Published: (2021-12-01)

The Specific Gravity-Free Method for the Isolation of Circulating Tumor KRAS Mutant DNA and Exosome in Colorectal Cancer
by: Tae Hee Lee, et al.
Published: (2021-08-01)

Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas
by: Valentina Condelli, et al.
Published: (2021-01-01)

Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
by: Yuta Adachi, et al.
Published: (2021-10-01)

Circulating Placental Vesicles Carry HLA-DR in Pre-Eclampsia: A New Potential Marker of the Syndrome
by: Chiara Tersigni, et al.
Published: (2021-09-01)

Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients
by: Lisa Salvatore, et al.
Published: (2023-02-01)

Safety and Efficacy of a First-Line Chemotherapy Tailored by G8 Score in Elderly Metastatic or Locally Advanced Gastric and Gastro-Esophageal Cancer Patients: A Real-World Analysis
by: Ina Valeria Zurlo, et al.
Published: (2022-09-01)

KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
by: Rita Chiari, et al.
Published: (2023-11-01)

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
by: Ke Xu, et al.
Published: (2019-04-01)

Multiple Myeloma-Derived Extracellular Vesicles Impair Normal Hematopoiesis by Acting on Hematopoietic Stem and Progenitor Cells
by: Ilaria Laurenzana, et al.
Published: (2021-12-01)

Cytokine Response to SARS-CoV-2 Infection in Children
by: Antonietta Curatola, et al.
Published: (2021-09-01)

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
by: Ke Xu, et al.
Published: (2020-05-01)

Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis
by: Armando Orlandi, et al.
Published: (2021-03-01)

Simplified structural map of Kras Kras (Slovene), Carso (Italian) = Geographical unit
by: Ladislav Placer
Published: (2015-07-01)

A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
by: Nicolas Bery, et al.
Published: (2020-06-01)

Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
by: Marc Cucurull, et al.
Published: (2022-01-01)

TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation
by: Giacomo Lettini, et al.
Published: (2020-10-01)

Acute Myeloid Leukemia Cells Functionally Compromise Hematopoietic Stem/Progenitor Cells Inhibiting Normal Hematopoiesis Through the Release of Extracellular Vesicles
by: Stefania Trino, et al.
Published: (2022-03-01)

KRAS signaling in malignant pleural mesothelioma
by: Antonia Marazioti, et al.
Published: (2022-02-01)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
by: Alice Indini, et al.
Published: (2021-05-01)

Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
by: Elisa Baldelli, et al.
Published: (2021-09-01)

Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression
by: Anquan Shang, et al.
Published: (2020-03-01)

Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
by: Emanuele Vita, et al.
Published: (2021-05-01)

Clinical Significance of the KRAS Mutation
by: Sead Beganovic
Published: (2010-10-01)

Targeting KRAS in Pancreatic Cancer
by: Darren Cowzer, et al.
Published: (2022-11-01)